Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1266 (LINC01266) is an autonomously transcribed lncRNA longer than 200 nucleotides, located between annotated coding genes in the genome. Although it is annotated in gene databases and may play regulatory roles characteristic of lincRNAs—including transcriptional and chromatin modulation, and acting as scaffolds for protein complexes—there is currently no direct evidence for its specific biological functions, disease association, or interaction with drugs. The gene is referenced in genomic studies such as copy number variation and GWAS datasets, which note its tissue-specific expression, but do not clarify its mechanistic role or therapeutic relevance. Like other lincRNAs, it may contribute to gene regulation, chromatin architecture, and RNA stabilization, but targeted research is needed to confirm these properties for LINC01266 specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1266 (LINC01266).